MedPath

A comparative study between chest wall nerve block vs conventional IV analgesics for post-operative pain management in breast cancer patients undergoing modified radical mastectomy.

Phase 4
Completed
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2023/10/058992
Lead Sponsor
Department of Anaesthesiology RIMS Ranchi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Adult female patients aged =18 year who will undergo elective MRM surgery at the RIMS,

RANCHI and who met the criteria of classes I–III of the American Society of Anesthesiology

(ASA) classification will be eligible for inclusion in the study

Exclusion Criteria

Age <18, pregnancy and refusal to participate in the study constituted the exclusion

criteria. Also, patients who would unconscious or mentally incompetent prior to surgery, or who

would in ASA classes IV or V, or had coagulopathy or hemodynamic instability (systolic blood

pressure <90 mmHg, mean arterial pressure <60 mmHg), or a history of opioid abuse or of

allergic reactions to opiates or to local anesthetic agents wil be excluded from the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of the level of post-operative pain (on NRS scores) <br/ ><br>Timepoint: Post-operative pain on NRS score at post-op 0,1,2,4,12 and 24 hours. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
(1) Time needed to the first rescue analgesic in minutes. <br/ ><br>(2) Cumulative dose of rescue analgesic needed (cumulative dose of tramadol & fentanyl). <br/ ><br>(3)Rate of patient satisfaction (on a 1 to 10 scale). <br/ ><br>(4)The incidence of nausea & any attack of post-operative vomiting <br/ ><br>(5)The incidence of any of the serratus anterior plane blocks complications e.g. injection site hematoma or signs or symptoms of local anesthetic toxicity. <br/ ><br> <br/ ><br>Timepoint: post-op period upto patient discharge.
© Copyright 2025. All Rights Reserved by MedPath